Medicure

Medicure company information, Employees & Contact Information

Explore related pages

Related company profiles:

Medicure Inc (TSXV:MPH) is a pharmaceutical company focused on the development and commercialization of cardiovascular medicines for the U.S. market. Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives. We take pride in providing safe, efficacious, and cost-effective cardiovascular medicines that benefit both patients and healthcare providers. Currently, we focus on the marketing & distribution of: 1. AGGRASTAT® (tirofiban hydrochloride) injections, a hospital-based product used in the cardiac catheterization lab. AGGRASTAT is the #1 used medication of its class in the U.S. 2. ZYPITAMAG® (pitavastatin) tablets, the latest statin medication approved by the FDA in 2017. In 2020, we acquired Marley Drug, a local pharmacy in North Carolina. Our acquisition of Marley Drug increases patient access to medications, including Medicure's primary care drug, ZYPITAMAG® (Pitavastatin) tablets. At Medicure, our passion drives us to innovate and find solutions to better support patients. For more information, please see our website at www.medicure.com and follow us on Twitter at @MedicureInc. For guidelines on engaging with Medicure on social media, please visit bit.ly/MedicureSocial

Company Details

Employees
172
Founded
-
Address
2-1250 Waverley Street, Winnipeg,manitoba R3t 6c6,canada
Phone
(888)435-2220
Email
in****@****ure.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Winnipeg, Manitoba
Looking for a particular Medicure employee's phone or email?

Medicure Questions

News

MEDICURE ANNOUNCES UPDATE ON ENROLLMENT IN ITS MEND-PNPO PHASE 3 CLINICAL TRIAL AND PRESENTATION OF THE TRIAL DESIGN AND BASELINE DATA AT THE 2025 CHILD NEUROLOGY SOCIETY CONFERENCE - biomb.ca

MEDICURE ANNOUNCES UPDATE ON ENROLLMENT IN ITS MEND-PNPO PHASE 3 CLINICAL TRIAL AND PRESENTATION OF THE TRIAL DESIGN AND BASELINE DATA AT THE 2025 CHILD NEUROLOGY SOCIETY CONFERENCE biomb.ca

Cardiology Catheters To Become Cheaper By 25-30% After PendraCare Acquisition: Poly Medicure MD - NDTV Profit

Cardiology Catheters To Become Cheaper By 25-30% After PendraCare Acquisition: Poly Medicure MD NDTV Profit

Top Breakout Stock Ideas: Analysts Pick Biocon, KFin Tech, Poly Medicure, Sammaan Capital And More - Stocktwits

Top Breakout Stock Ideas: Analysts Pick Biocon, KFin Tech, Poly Medicure, Sammaan Capital And More Stocktwits

Poly Medicure Acquires Netherlands-Based PendraCare To Expand Global Cardiology Business - BW Healthcare World

Poly Medicure Acquires Netherlands-Based PendraCare To Expand Global Cardiology Business BW Healthcare World

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property - Yahoo Finance

Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property Yahoo Finance

Poly Medicure shares jump 5% on plans to acquire Citieffe Group for ₹324-cr - Business Standard

Poly Medicure shares jump 5% on plans to acquire Citieffe Group for ₹324-cr Business Standard

Poly Medicure cuts FY26 revenue guidance amid Europe slowdown, domestic market stays robust - CNBC TV18

Poly Medicure cuts FY26 revenue guidance amid Europe slowdown, domestic market stays robust CNBC TV18

Poly Medicure inks second European M&A deal in a month - VCCircle

Poly Medicure inks second European M&A deal in a month VCCircle

Poly Medicure Acquires PendraCare Group to Expand Global Cardiology Biz - Digital Health News

Poly Medicure Acquires PendraCare Group to Expand Global Cardiology Biz Digital Health News

Stocks to buy: Nagaraj Shetti recommends Poly Medicure, Oil India shares to buy - Mint

Stocks to buy: Nagaraj Shetti recommends Poly Medicure, Oil India shares to buy Mint

Poly Medicure acquires Italy’s Citieffe for ₹324 crore, expands into global orthopaedics - BusinessLine

Poly Medicure acquires Italy’s Citieffe for ₹324 crore, expands into global orthopaedics BusinessLine

Poly Medicure Acquires PendraCare Group Stake - Rediff MoneyWiz

Poly Medicure Acquires PendraCare Group Stake Rediff MoneyWiz

FDA Approves New Aggrastat (Tirofiban) Product Format - HMP Global Learning Network

FDA Approves New Aggrastat (Tirofiban) Product Format HMP Global Learning Network

Poly Medicure to invest ₹500 cr in new plants for global market push - Business Standard

Poly Medicure to invest ₹500 cr in new plants for global market push Business Standard

Poly Medicure gets Medical Device Regulation certification for its 54 products in Europe - CNBC TV18

Poly Medicure gets Medical Device Regulation certification for its 54 products in Europe CNBC TV18

Poly Medicure (NSE:POLYMED) Will Pay A Larger Dividend Than Last Year At ₹3.50 - simplywall.st

Poly Medicure (NSE:POLYMED) Will Pay A Larger Dividend Than Last Year At ₹3.50 simplywall.st

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results - Yahoo Finance

Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results Yahoo Finance

Are Poly Medicure Limited's (NSE:POLYMED) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st

Are Poly Medicure Limited's (NSE:POLYMED) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? simplywall.st

Poly Medicure Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st

Poly Medicure Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year simplywall.st

Medicure : Announces Resignation of Chief Financial Officer and Succession Plan - MarketScreener

Medicure : Announces Resignation of Chief Financial Officer and Succession Plan MarketScreener

Poly Medicure Expands Global Footprint with Strategic Acquisitions, Schedules Investor Call - scanx.trade

Poly Medicure Expands Global Footprint with Strategic Acquisitions, Schedules Investor Call scanx.trade

Poly Medicure to acquire Netherlands-based PendraCare for ₹188.5 crore - Business Standard

Poly Medicure to acquire Netherlands-based PendraCare for ₹188.5 crore Business Standard

Medical Devices Demand To Surge If GST Rate Slashed, Says Poly Medicure MD - NDTV Profit

Medical Devices Demand To Surge If GST Rate Slashed, Says Poly Medicure MD NDTV Profit

Poly Medicure eyes $15-20 million US revenue by 2030 from Medistream deal - CNBC TV18

Poly Medicure eyes $15-20 million US revenue by 2030 from Medistream deal CNBC TV18

Poly Medicure share price: Pharma stock jumps 2%; to fully acquire Citieffe Group - Should you BUY? - ET Now

Poly Medicure share price: Pharma stock jumps 2%; to fully acquire Citieffe Group - Should you BUY? ET Now

Poly Medicure eyes growth in interventional cardiology and expansion in key international markets - CNBC TV18

Poly Medicure eyes growth in interventional cardiology and expansion in key international markets CNBC TV18

Poly Medicure secures EU MDR Certification for 54 medical devices - Express Healthcare

Poly Medicure secures EU MDR Certification for 54 medical devices Express Healthcare

Poly Medicure Reports Revenue Growth to 4B Rupees in Q1 Results - scanx.trade

Poly Medicure Reports Revenue Growth to 4B Rupees in Q1 Results scanx.trade

Poly Medicure Q4 results: Profit rises 34% on strong exports, new divisions - Business Standard

Poly Medicure Q4 results: Profit rises 34% on strong exports, new divisions Business Standard

Poly Medicure targets global markets with Rs 500 crore investment and strategic acquisitions - Business Today

Poly Medicure targets global markets with Rs 500 crore investment and strategic acquisitions Business Today

Poly Medicure shares gain on acquisition of Netherlands based company - Moneycontrol

Poly Medicure shares gain on acquisition of Netherlands based company Moneycontrol

Poly Medicure Completes PendraCare Group Acquisition, Secures 90% Economic Rights - scanx.trade

Poly Medicure Completes PendraCare Group Acquisition, Secures 90% Economic Rights scanx.trade

Poly Medicure posts Q1 FY25 consolidated PAT at Rs. 74.03 Cr - Indian Pharma Post

Poly Medicure posts Q1 FY25 consolidated PAT at Rs. 74.03 Cr Indian Pharma Post

Poly Medicure Set to Benefit from Potential GST Rate Cut on Medical Devices - scanx.trade

Poly Medicure Set to Benefit from Potential GST Rate Cut on Medical Devices scanx.trade

Poly Medicure projects strong growth and margin expansion in FY25 - CNBC TV18

Poly Medicure projects strong growth and margin expansion in FY25 CNBC TV18

Poly Medicure to deploy Rs 1,000 cr fundraise for capex, future buys - Business Standard

Poly Medicure to deploy Rs 1,000 cr fundraise for capex, future buys Business Standard

Poly Medicure Sets ₹3.50 Dividend, Record Date Sept 18 - HDFC Sky

Poly Medicure Sets ₹3.50 Dividend, Record Date Sept 18 HDFC Sky

AMPIN Signs Pact With Poly Medicure To Boost Solarisation - Saur Energy

AMPIN Signs Pact With Poly Medicure To Boost Solarisation Saur Energy

Poly Medicure Signs JV with AMPIN to Set Up Captive Solar Plant in Haryana - Energetica India Magazine

Poly Medicure Signs JV with AMPIN to Set Up Captive Solar Plant in Haryana Energetica India Magazine

Poly Medicure raises ₹1,000 crore by selling shares to at least seven major funds - CNBC TV18

Poly Medicure raises ₹1,000 crore by selling shares to at least seven major funds CNBC TV18

AMPIN Energy Transition Partners With Poly Medicure For 10MWp Solar Power Project In Haryana - SolarQuarter

AMPIN Energy Transition Partners With Poly Medicure For 10MWp Solar Power Project In Haryana SolarQuarter

Poly Medicure shares rally after successfully raising Rs 1,000 cr via QIP - Business Standard

Poly Medicure shares rally after successfully raising Rs 1,000 cr via QIP Business Standard

Rs 2,000 or 2,650? Poly Medicure shares up 12%; here are target prices - Business Today

Rs 2,000 or 2,650? Poly Medicure shares up 12%; here are target prices Business Today

Poly Medicure Ltd. forges its new brand identity - ANI News

Poly Medicure Ltd. forges its new brand identity ANI News

Poly Medicure looking at acquisition opportunities; expects 12-15% growth in FY21 - CNBC TV18

Poly Medicure looking at acquisition opportunities; expects 12-15% growth in FY21 CNBC TV18

Poly Medicure Ltd Share Price Today, POLYMED Share Price NSE, BSE - Business Today

Poly Medicure Ltd Share Price Today, POLYMED Share Price NSE, BSE Business Today

Stay away from Medicure, says Mackie Research - Cantech Letter

Stay away from Medicure, says Mackie Research Cantech Letter

%%title%% %%page%% - Cantech Letter

%%title%% %%page%% Cantech Letter

Poly Medicure completes acquisition of Plan I Health - Udaipur Kiran

Poly Medicure completes acquisition of Plan I Health Udaipur Kiran

Top Medicure Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant